logo-large
  • Browse Categories

Publications by authors named "Shogo Yanase"

Claim this Profile
I
Inhibiting KRAS with CD47 and immune checkpoint overcomes intrinsic resistance to combined KRAS and immune checkpoint inhibitor therapy.
Kentaro Hirade, Noritaka Tanaka, Taisuke Kajino, Yuta Adachi, Ryo Kimura, Shogo Yanase

Cell Rep Med· September 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Ryo Kimura, Yuta Adachi, Kentaro Hirade, Satoru Kisoda, Shogo Yanase

Cancers (Basel)· October 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS.
Yuta Adachi, Ryo Kimura, Kentaro Hirade, Shogo Yanase, Yuki Nishioka

Nat Cancer· June 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer.
Carlotta Costa, Ye Wang, Amy Ly, Yasuyuki Hosono, Ellen Murchie, Shogo Yanase

Cancer Discov· January 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: